🇺🇸 LGND — Ligand Pharmaceuticals Incorporated

Salud Compra fuerte
← Volver

Precio actual

299,00 USD

Máx. histórico

322,75

6 días

Split 1603:1000 del 02/11/2022

Caída desde máximo

-7,36%

Rango 52 semanas

175,89 – 326,63

Variación hoy

-5,42%

Cierre anterior

316,13

Rango de hoy

297,63 – 318,98

Volumen hoy

247.610

Peor caída histórica

-93,34%

06/03/2000 → 19/11/2008

Recuperado en 2694 días

Volatilidad anualizada ⓘ

59,76%

Información
Nombre completo
Ligand Pharmaceuticals Incorporated
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
47
PER ⓘ
120,08 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
350,92 USD (puede no estar actualizado)
Primera cotización
18/11/1992
Precio actualizado
hace 21 horas
Sobre la empresa

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.

Dividendos repartidos Total últimos 12 meses: 0,0000 USD · Yield: 0,00%
Fecha de pago Importe por participación
03/04/2007 9,3575 USD
Splits Registrados en el histórico de precios
Fecha Ratio
02/11/2022 1603:1000
19/11/2010 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
18/06/1998 49,59 49,59 47,26 47,49 -6,02% 4,72% 27.251
17/06/1998 50,76 51,93 50,53 50,53 +0,00% 2,76% 41.010
16/06/1998 48,66 50,53 47,72 50,53 +8,00% 5,77% 67.486
15/06/1998 47,49 47,72 45,62 46,79 -1,96% 4,43% 26.743
12/06/1998 48,19 48,19 45,85 47,72 +0,00% 4,85% 43.281
11/06/1998 49,36 49,59 47,26 47,72 -2,86% 4,74% 29.549
10/06/1998 49,36 50,30 48,66 49,13 -1,87% 3,32% 23.778
09/06/1998 49,13 50,53 49,13 50,06 +0,94% 2,86% 23.244
08/06/1998 50,06 50,53 49,59 49,59 -0,47% 1,87% 28.507
05/06/1998 49,83 50,30 49,13 49,83 +1,43% 2,35% 38.472
04/06/1998 47,72 49,83 47,26 49,13 +0,96% 5,39% 49.800
03/06/1998 50,06 51,00 47,26 48,66 -1,89% 7,48% 121.160
02/06/1998 51,93 53,28 48,66 49,59 -3,64% 8,90% 224.874
01/06/1998 51,70 52,40 50,53 51,47 -1,35% 3,62% 57.120
29/05/1998 53,34 53,34 52,17 52,17 -2,19% 2,19% 55.063
28/05/1998 51,93 53,34 51,70 53,34 +4,11% 3,15% 193.215
27/05/1998 52,87 52,87 50,53 51,23 -3,10% 4,42% 97.142
26/05/1998 54,74 54,74 52,87 52,87 -2,16% 3,42% 128.721
22/05/1998 54,74 54,74 53,81 54,04 -0,43% 1,71% 23.217
21/05/1998 54,74 55,44 54,04 54,27 -0,43% 2,56% 30.644
20/05/1998 55,68 55,91 54,51 54,51 -1,27% 2,52% 96.607
19/05/1998 54,27 56,14 53,81 55,21 +2,61% 4,31% 137.644
18/05/1998 55,68 55,68 53,34 53,81 -0,43% 4,20% 68.795
15/05/1998 53,57 54,04 52,87 54,04 +2,21% 2,18% 53.567
14/05/1998 52,40 53,57 51,93 52,87 +1,35% 3,12% 104.355
13/05/1998 52,64 52,87 51,23 52,17 -1,33% 3,11% 61.395
12/05/1998 53,34 53,34 51,93 52,87 +1,80% 2,63% 64.280
11/05/1998 52,87 53,34 51,93 51,93 -0,89% 2,65% 83.062
08/05/1998 52,40 53,34 51,93 52,40 +0,45% 2,68% 126.290
07/05/1998 52,64 52,64 51,47 52,17 +0,45% 2,22% 37.697